1. Vakhitova Yu. V., Antipina E. I., Yamidanov R. S., Khisamutdinova R. Yu. Identification of target genes 5-amino-exo-3-azatricyclo [5.2.1.02,6] decan-4-one in vivo model of arrhythmia. Bioorganic chemistry. 2011; 6 (37): 9–11. Doi.org/10.1134/S1068162011060148 (In Russ.).
2. Mironov A. N. Bunatjan N. D. Guidelines for conducting preclinical studies of drugs. – M.: Grief and K, 2012; 944 р. (In Russ.).
3. Modern methods in biochemistry / Under. ed. Acad. V. N. Orekhovich. – M.: Medicine. 1977; Pp. 66–68 (In Russ.).
4. Khisamutdinova R. Yu., Sapozhnikova T. A., Makara N. S., Gabdrakhmanova S. F., Zarudii F. C. Experimental study of the antiarrhythmic activity and chronic toxicity of 5-amino-exo-3- azatricyclo [5.2.1.02,6] decan-4-one. Drugs development & registration. 2015; 2 (11): 90–93 (In Russ.).
5. Tsypysheva I. P., Koval’skaya A. V., Makara N. S., Lobov A. N., Petrenko I. A., Galkin E. G., Sapozhnikova T. A., Zarudii F. C., Yunusov M. S. Synthesis and specific nootropic activity of derivatives (-)-cytisine, having in its structure fragments of carbamides and thiocarbamides. Chemistry of natural compounds. 2012; 4: 565. Doi.org/10.1007/s10600-012-0329-7. (In Russ.).